Parental magnetic resonance imaging for the evaluation of fetuses with brain anomalies.
Journal
Developmental medicine and child neurology
ISSN: 1469-8749
Titre abrégé: Dev Med Child Neurol
Pays: England
ID NLM: 0006761
Informations de publication
Date de publication:
11 Sep 2024
11 Sep 2024
Historique:
revised:
08
07
2024
received:
04
03
2024
accepted:
17
07
2024
medline:
11
9
2024
pubmed:
11
9
2024
entrez:
11
9
2024
Statut:
aheadofprint
Résumé
To evaluate the role of parental magnetic resonance imaging (MRI) in assessing fetuses with suspected brain anomalies and its use in prenatal counselling. A retrospective, multicentre chart review was conducted on fetuses who underwent brain MRI because of suspected brain abnormalities between January 2008 and December 2022, with one or both parents who underwent brain MRI (MRI-Trio) as part of prenatal counselling. Clinical and demographic data were collected, including fetal and parental MRI findings, prenatal counselling outcomes, genetic testing results, family and previous pregnancy history, neurological examinations of the born children up to 24 months of age, and autopsy reports of fetuses from terminated pregnancies. MRI-Trio concordance was defined as at least one abnormal brain feature identified with similarity in the fetus and the parents. The live-born children were assessed postnatally through either neurodevelopmental evaluations or telephone interviews. Sixty pregnancies were included (41.7% with concordant and 58.3% with discordant MRI-Trio). Forty-two children were born (70%) and 17 pregnancies were terminated (28.3%). One case of in utero fetal death (1.7%) was reported. The most common brain findings were multiple anomalies (n = 26, 43.3%), isolated disorders of the corpus callosum (n = 17, 28.3%), atypical periventricular pseudocysts (n = 6, 10%), and anomalies of the anterior complex (n = 4, 6.7%). MRI-Trio enabled better prognostication. When MRI-Trio was concordant, counselling was more favourable (n = 22, 36.6%) and the majority of live-born children exhibited typical development (p < 0.001). MRI-Trio is a valuable tool for identifying dominantly inherited brain anomalies that may not hold developmental significance or are associated with favourable outcomes, acknowledging the potential for variable penetrance, which may result in more severe presentations. Concordant MRI-Trio findings can enhance the accuracy of prenatal counselling, potentially reducing the incidence of termination of pregnancy.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac Keith Press.
Références
Scher MS. Fetal neurology: Principles and practice with a life‐course perspective. Handb Clin Neurol. 2019;162:1–29.
Smyser CD, Tam EWY, Chang T, Soul JS, Miller SP, Glass HC. Fellowship Training in the Emerging Fields of Fetal‐Neonatal Neurology and Neonatal Neurocritical Care. Pediatric Neurology. 2016;63:39‐44.e3.
Iruretagoyena JI, Shah D, Malinger G. Dedicated fetal neurosonographic evaluation improves patient care and maternal fetal medicine fellow training. J Matern Fetal Neonatal Med. 2016;29(3):482–6.
Sonographic examination of the fetal central nervous system: guidelines for performing the ‘basic examination’ and the ‘fetal neurosonogram’. Ultrasound Obstet Gynecol. 2007;29(1):109–16.
Lerman‐Sagie T, Pogledic I, Leibovitz Z, Malinger G. A practical approach to prenatal diagnosis of malformations of cortical development. Eur J Paediatr Neurol. 2021;34:50–61.
Scher MS. An interdisciplinary fetal/neonatal neurology program. J Child Neurol. 2012;27(4):496–502.
Dan B. Fetal neurology has lifelong relevance. Dev Med Child Neurol. 2023;65(9):1130–1.
Scelsa B. Fetal Neurology: From Prenatal Counseling to Postnatal Follow‐Up. Diagnostics (Basel). 2022;12(12).
Batty R, Gawne‐Cain ML, Mooney C, Mandefield L, Bradburn M, Mason G, et al. Analysis of errors made on in utero MR studies of the foetal brain in the MERIDIAN study. Eur Radiol. 2019;29(1):195–201.
Griffiths PD, Bradburn M, Campbell MJ, Cooper CL, Graham R, Jarvis D, et al. Use of MRI in the diagnosis of fetal brain abnormalities in utero (MERIDIAN): a multicentre, prospective cohort study. Lancet. 2017;389(10068):538–46.
Melcer Y, Maymon R, Krajden Haratz K, Goldrat I, Shavit M, Ben‐Ami I, et al. Termination of pregnancy due to fetal central nervous system abnormalities performed after 24 weeks' gestation: survey of 57 fetuses from a single medical center. Arch Gynecol Obstet. 2018;298(3):551–9.
Chervenak FA, McCullough LB, Campbell S. Is third trimester abortion justified? Br J Obstet Gynaecol. 1995;102(6):434–5.
Chervenak FA, McCullough LB. Ethical dimensions of fetal neurology. Semin Fetal Neonatal Med. 2012;17(5):252–5.
Petrovski S, Aggarwal V, Giordano JL, Stosic M, Wou K, Bier L, et al. Whole‐exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study. Lancet. 2019;393(10173):758–67.
Lee H, Deignan JL, Dorrani N, Strom SP, Kantarci S, Quintero‐Rivera F, et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. Jama. 2014;312(18):1880–7.
Wright CF, Fitzgerald TW, Jones WD, Clayton S, McRae JF, van Kogelenberg M, et al. Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome‐wide research data. Lancet. 2015;385(9975):1305–14.
Pauta M, Martinez‐Portilla RJ, Meler E, Otaño J, Borrell A. Diagnostic yield of exome sequencing in isolated fetal growth restriction: Systematic review and meta‐analysis. Prenat Diagn. 2023;43(5):596–604.
Yaron Y, Ofen Glassner V, Mory A, Zunz Henig N, Kurolap A, Bar Shira A, et al. Exome sequencing as first‐tier test for fetuses with severe central nervous system structural anomalies. Ultrasound Obstet Gynecol. 2022;60(1):59–67.
Viñals F, Correa F, Gonçalves‐Pereira PM. Anterior and posterior complexes: a step towards improving neurosonographic screening of midline and cortical anomalies. Ultrasound Obstet Gynecol. 2015;46(5):585–94.
Heide S, Argilli E, Valence S, Boutaud L, Roux N, Mignot C, et al. Loss‐of‐function variants in ZEB1 cause dominant anomalies of the corpus callosum with favourable cognitive prognosis. J Med Genet. 2023.
Tsai P, Shinar S. Agenesis of the corpus callosum: What to tell expecting parents? Prenat Diagn. 2023;43(12):1527–35.
Hart AR, Vasudevan C, Griffiths PD, Foulds N, Piercy H, de Lacy P, et al. Antenatal counselling for prospective parents whose fetus has a neurological anomaly: part 2, risks of adverse outcome in common anomalies. Dev Med Child Neurol. 2022;64(1):23–39.
D'Antonio F, Pagani G, Familiari A, Khalil A, Sagies TL, Malinger G, et al. Outcomes Associated With Isolated Agenesis of the Corpus Callosum: A Meta‐analysis. Pediatrics. 2016;138(3).
Nguyen T, Heide S, Guilbaud L, Valence S, Perre SV, Blondiaux E, et al. Abnormalities of the corpus callosum. Can prenatal imaging predict the genetic status? Correlations between imaging phenotype and genotype. Prenat Diagn. 2023.
Heide S, Spentchian M, Valence S, Buratti J, Mach C, Lejeune E, et al. Prenatal exome sequencing in 65 fetuses with abnormality of the corpus callosum: contribution to further diagnostic delineation. Genet Med. 2020;22(11):1887–91.
Hagege R, Haratz KK, Malinger G, Ben‐Sira L, Leibovitz Z, Heron D, et al. Spectrum of brain malformations in fetuses with ‘mild’ tubulinopathies. Ultrasound Obstet Gynecol. 2022.